| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EXPLORE.2010.06.004 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S1550830710001291?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:S1550830710001291?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 20832765 |
| P5875 | ResearchGate publication ID | 46219265 |
| P2093 | author name string | Seong-Gyu Ko | |
| Zhao-Xiang Bian | |||
| Chung-Wah Cheng | |||
| Lisa Song | |||
| Wing Fan | |||
| P2860 | cites work | Medicinal herbs for esophageal cancer | Q24243001 |
| Chinese medical herbs for chemotherapy side effects in colorectal cancer patients | Q24245113 | ||
| Complementary medicine in Europe | Q24648748 | ||
| Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology | Q28140688 | ||
| Herb-drug interactions in oncology: focus on mechanisms of induction | Q28255139 | ||
| Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey | Q29547851 | ||
| Evaluating complementary and alternative therapies for cancer patients. | Q30327857 | ||
| Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China. | Q30356818 | ||
| Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005 | Q31107718 | ||
| Pharmacokinetic interactions of drugs with St John's wort | Q33204911 | ||
| Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials. | Q33231959 | ||
| A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity | Q33373894 | ||
| Cancer patients' attitudes towards Chinese medicine: a Hong Kong survey | Q33587343 | ||
| Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition | Q33834603 | ||
| Drug interactions in palliative care | Q33891507 | ||
| Dietary supplement use in cancer care: help or harm | Q34012851 | ||
| Effect of grapefruit juice intake on etoposide bioavailability | Q34155326 | ||
| Molecular mechanisms underlying St. John's wort drug interactions | Q34902089 | ||
| Herbal remedies | Q35029813 | ||
| Interaction of St John's wort with conventional drugs: systematic review of clinical trials | Q35615173 | ||
| Herbal remedies in the United States: potential adverse interactions with anticancer agents | Q35805195 | ||
| Drug interactions in oncology | Q35853032 | ||
| Dietary antioxidants and human cancer | Q35937796 | ||
| Natural health products and drug disposition | Q36094565 | ||
| Herbal medicine and cancer: an introductory overview | Q36224807 | ||
| Natural health product-drug interactions: a systematic review of clinical trials | Q36262926 | ||
| Natural health product interactions with medication | Q36278312 | ||
| An approach to evaluating drug-nutrient interactions | Q36320632 | ||
| In vitro and in vivo assessment of herb drug interactions | Q36373893 | ||
| From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. | Q36379379 | ||
| Potential synergism of natural products in the treatment of cancer | Q36430280 | ||
| Bringing evidence to complementary and alternative medicine for children with cancer | Q36470795 | ||
| A strategy for controlling potential interactions between natural health products and chemotherapy: a review in pediatric oncology | Q36710712 | ||
| Modulation of response to cancer chemotherapeutic agents by diet constituents: is the available evidence sufficiently robust for rational advice for patients? | Q36747595 | ||
| Metabolism of dietary polyphenols and possible interactions with drugs | Q36855294 | ||
| Clinical guide to herb-drug interactions in oncology | Q36924494 | ||
| Identification and exploration of herb-drug combinations used by cancer patients | Q44429983 | ||
| In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products | Q44479610 | ||
| Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. | Q50785239 | ||
| Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). | Q50885609 | ||
| Risks associated with herbal medicinal products. | Q53670009 | ||
| Religiosity is associated with the use of complementary medical therapies by pediatric oncology patients. | Q54739806 | ||
| Improving the quality of randomized controlled trials in Chinese herbal medicine, Part Ⅲ: quality control of Chinese herbal medicine used in randomize | Q56880314 | ||
| Articles on Complementary Medicine in the Mainstream Medical Literature | Q57914476 | ||
| Herbal use among cancer patients during palliative or curative chemotherapy treatment in Norway | Q61919078 | ||
| Potential of chemotherapy?herb interactions in adult cancer patients | Q63169981 | ||
| Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide | Q74234923 | ||
| Integrative medicine: sorting fact from fiction | Q80799875 | ||
| Use of complementary and alternative medicine among patients with cancer receiving outpatient chemotherapy in Taiwan | Q81150069 | ||
| The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care | Q81692097 | ||
| Herb-drug interaction implications in pediatric practice: an overview of pharmacokinetic trials | Q81924000 | ||
| [Dietary supplements: watch for interactions!] | Q83932434 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 324-329 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Explore: the Journal of Science and Healing | Q15816952 |
| P1476 | title | Evidence-based management of herb-drug interaction in cancer chemotherapy | |
| Evidence-Based Management of Herb-Drug Interaction in Cancer Chemotherapy | |||
| P478 | volume | 6 |
| Q91671335 | An evaluation of randomized controlled trials on nutraceuticals containing traditional Chinese medicines for diabetes management: a systematic review |
| Q33567159 | Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME. |
| Q89623444 | Biologically-Based Complementary and Alternative Medicine (CAM) Use in Cancer Patients: The Good, the Bad, the Misunderstood |
| Q64962031 | Chinese Herbal Medicine (Xiaoaiping) Injections for Chemotherapy-Induced Thrombocytopenia: A Randomized, Controlled, Multicenter Clinical Trial. |
| Q35746339 | Comparing Health-Care Providers' Perspectives on Complementary and Alternative Medicine in Childhood Cancer Between Netherlands and Indonesia |
| Q48110776 | Development of a rapid risk evaluation tool for herbs/drugs interactions in cancer patients: a multicentric experience in south of France |
| Q50224638 | Discrepant Views of Oncologists and Cancer Patients on Complementary and Alternative Medicine in a Chinese General Hospital. |
| Q46675810 | Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients |
| Q36111593 | Emerging glycolysis targeting and drug discovery from chinese medicine in cancer therapy |
| Q34306204 | Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review |
| Q26751162 | Gynura procumbens: An Overview of the Biological Activities |
| Q24598351 | Impact of fixed-dose combination of germacrone, curdione, and furanodiene on breast cancer cell proliferation |
| Q93556711 | In Reply |
| Q55510566 | Integration of botanicals in contemporary medicine: road blocks, checkpoints and go-ahead signals. |
| Q34034102 | Momordica charantia Extract Induces Apoptosis in Human Cancer Cells through Caspase- and Mitochondria-Dependent Pathways |
| Q37706639 | National survey of China's oncologists' knowledge, attitudes, and clinical practice patterns on complementary and alternative medicine |
| Q36012951 | Prevalence of Polyherbacy in Ambulatory Visits to Traditional Chinese Medicine Clinics in Taiwan |
| Q38348599 | Safety of Chinese herbal medicines during pregnancy. |
| Q38068221 | Theranostics meets traditional Chinese medicine: rational prediction of drug-herb interactions |
| Q37959231 | Traditional Chinese medicine in cancer care: a review of case reports published in Chinese literature |
| Q37217878 | Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries |
| Q33886054 | Understanding CAM Natural Health Products: Implications of Use Among Cancer Patients and Survivors. |
Search more.